nilutamide has been researched along with acid phosphatase in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 9 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, DA; Miesfeld, RL; Rundlett, SE | 1 |
| Beland, G | 1 |
| Bolt, J; Mulder, E; Schuurmans, AL; Veldscholte, J | 1 |
| Debruyne, FM; Dijkman, GA; Fernandez del Moral, P; Mulders, PF; Theeuwes, AG | 1 |
| Billebaud, T; Costa, P; Dahan, R; Fiet, J; Grise, P; Husson, JM; Kuhn, JM; Louis, JF; Moulonguet, A; Navratil, H | 1 |
| Navratil, H | 1 |
| Belanger, A; Dupont, A; Fazekas, AT; Gareau, J; Husson, JM; Labrie, F; Lacoursiere, Y; Monfette, G; Raynaud, JP; Sandow, J | 1 |
| Faure, N; Fazekas, AT; Jean, C; Laroche, B; Lemay, A; Plante, R; Robert, G; Roy, R; Thabet, M | 1 |
| Belanger, A; Dupont, A; Labrie, F; Lefebvre, FA; Raynaud, JP | 1 |
| Bélanger, A; Dupont, A; Emond, J; Labrie, F; Monfette, G | 1 |
| Abbou, CC; Bartoletti, R; Bernstein-Hahn, L; Bracken, B; Brisset, JM; Chisholm, G; Crawford, ED; Da Silva, FC; Debruyne, FM; Janknegt, RA | 1 |
| Akimoto, S; Kitagawa, N; Masai, M; Nakamura, T; Shimazaki, J | 1 |
| Bertagna, C; De Géry, A; François, JP; Hucher, M; Zanirato, J | 1 |
| Abbou, CC; deGery, A; Janknegt, RA; Lange, PH; Smith, JA | 1 |
| Akakura, K; Akimoto, S; Inomiya, H; Ito, H; Shimazaki, J | 1 |
2 review(s) available for nilutamide and acid phosphatase
| Article | Year |
|---|---|
[New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
Topics: Acid Phosphatase; Androgen Antagonists; Buserelin; Drug Synergism; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Hormones; Humans; Imidazoles; Imidazolidines; Male; Prostate; Prostatic Neoplasms | 1983 |
Efficacy of the combination of nilutamide plus orchidectomy in patients with metastatic prostatic cancer. A meta-analysis of seven randomized double-blind trials (1056 patients).
Topics: Acid Phosphatase; Alkaline Phosphatase; Androgen Antagonists; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Double-Blind Method; Humans; Imidazoles; Imidazolidines; Male; Odds Ratio; Orchiectomy; Prostate; Prostatic Neoplasms; Randomized Controlled Trials as Topic | 1994 |
6 trial(s) available for nilutamide and acid phosphatase
| Article | Year |
|---|---|
Combination of Anandron with orchiectomy in treatment of metastatic prostate cancer. Results of a double-blind study.
Topics: Acid Phosphatase; Androgen Antagonists; Combined Modality Therapy; Double-Blind Method; Humans; Imidazoles; Imidazolidines; Male; Orchiectomy; Pain; Prostatic Neoplasms; Survival Rate | 1991 |
Analysis of prognostic factors in disseminated prostatic cancer. An update. Dutch Southeastern Urological Cooperative Group.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Alkaline Phosphatase; Androgen Antagonists; Antineoplastic Agents; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Multicenter Studies as Topic; Prognosis; Prostate; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Survival Rate; Testosterone | 1990 |
Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide).
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Buserelin; Drug Evaluation; Humans; Imidazoles; Imidazolidines; Male; Multicenter Studies as Topic; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone | 1989 |
Double-blind study of Anandron versus placebo in stage D2 prostate cancer patients receiving buserelin. Results on 49 cases from a multicentre study.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Clinical Trials as Topic; Double-Blind Method; Humans; Imidazoles; Imidazolidines; Male; Prostatic Neoplasms | 1987 |
Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial.
Topics: Acid Phosphatase; Actuarial Analysis; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Orchiectomy; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Analysis | 1993 |
Serum markers as a predictor of response duration and patient survival after hormonal therapy for metastatic carcinoma of the prostate.
Topics: Acid Phosphatase; Alkaline Phosphatase; Androgen Antagonists; Antineoplastic Agents, Hormonal; Bone Neoplasms; Disease Progression; Disease-Free Survival; Humans; Imidazoles; Imidazolidines; Leuprolide; Male; Multivariate Analysis; Orchiectomy; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Time Factors | 1997 |
7 other study(ies) available for nilutamide and acid phosphatase
| Article | Year |
|---|---|
Characterization of a panel of rat ventral prostate epithelial cell lines immortalized in the presence or absence of androgens.
Topics: Acid Phosphatase; Androgen Antagonists; Animals; Antigens, Polyomavirus Transforming; Blotting, Western; Cell Line; Cell Line, Transformed; Chloramphenicol O-Acetyltransferase; Culture Techniques; Epithelial Cells; Epithelium; Imidazoles; Imidazolidines; Karyotyping; Male; Metribolone; Orchiectomy; Polymerase Chain Reaction; Prostate; Rats; Rats, Sprague-Dawley; Receptors, Androgen; RNA, Messenger; Simian virus 40; Testosterone; Transfection | 1992 |
Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion.
Topics: Acid Phosphatase; Androgen Antagonists; Antineoplastic Agents; Cyproterone; Cyproterone Acetate; ErbB Receptors; Estradiol; Humans; Imidazoles; Imidazolidines; Male; Prostatic Neoplasms; Tumor Cells, Cultured | 1990 |
New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Buserelin; Drug Therapy, Combination; Hormones; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Prostatic Neoplasms; Radiography; Testosterone | 1983 |
Preliminary results on the clinical efficacy and safety of androgen inhibition by an LHRH agonist alone or combined with an antiandrogen in the treatment of prostatic carcinoma.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Bone and Bones; Buserelin; Castration; Drug Therapy, Combination; Hormones; Humans; Imidazoles; Imidazolidines; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Radiography; Testis; Testosterone | 1983 |
Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer.
Topics: Acid Phosphatase; Adenocarcinoma; Androgen Antagonists; Buserelin; Drug Therapy, Combination; Humans; Imidazoles; Imidazolidines; Male; Prostatic Neoplasms; Testosterone | 1984 |
[Determination of tumor marker doubling time in the patients with prostate cancer relapsed from endocrine therapy].
Topics: Acid Phosphatase; Alkaline Phosphatase; Antineoplastic Agents; Biomarkers, Tumor; Humans; Imidazoles; Imidazolidines; Male; Neoplasm Recurrence, Local; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Secretory Proteins; Proteins; Seminal Plasma Proteins; Time Factors | 1993 |
Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Alkaline Phosphatase; Analysis of Variance; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chlormadinone Acetate; Cisplatin; Disease Progression; Estrogens; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Imidazolidines; Karnofsky Performance Status; Lactates; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Orchiectomy; Progesterone Congeners; Prognosis; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Survival Rate | 1997 |